首页> 外文期刊>Nephrology. >Andrographolide induced acute kidney injury: Analysis of 26 cases reported in Chinese Literature
【24h】

Andrographolide induced acute kidney injury: Analysis of 26 cases reported in Chinese Literature

机译:穿心莲内酯致急性肾损伤:中国文献报道26例分析

获取原文
获取原文并翻译 | 示例
           

摘要

Aim Some Chinese herbs have been known for their kidney toxicity. Andrographolide, the primary component of a traditional medicinal herb, Andrographis paniculata, is widely used in China for the treatment of upper and lower respiratory tract infection, and dysentery etc. The aim of the study was to identify and summarize any case of kidney injury attributed to its use in the Chinese literature. Methods A systemic analysis of the Chinese literature from January 1978 to August 2013 was conducted of case reports of andrographolide induced acute kidney injury (AKI). Results We identified 26 cases of andrographolide induced AKI (22 males and four females), with an average age of 31.3 years (range: 21 months to 47 years). 100-750 mg (58% 500 mg) of andrographolide was administered in 100-500 mL 5% glucose solution or normal saline by intravenous drip once a day. The adverse event appeared after one to six doses (19 [73.1%] patients got only one dose; cumulative dose 690 ± 670 mg) of andrographolide was given, or 0-96 h (median 1 h) after andrographolide was given. The symptoms included flank pain in 23 cases (88.5%), decreased urine volume in five cases (19.2%), and nausea or vomiting in six cases (23.1%). Laboratory tests showed maximum creatinine 352.8 ± 184.1 (158-889) μmol/L and blood urea nitrogen 12.1 ± 7.6 (4.0-40.6) mmol/L. Urine analysis showed proteinuria in 10 (38.5%) cases and occult blood in eight (30.8%) cases. Kidney biopsy was carried out in two cases and both revealed acute tubular necrosis. Management of this adverse event included withdrawal of the culprit drug, conservative therapy, and renal replacement therapy (six cases, 23.1%). All the patients recovered and were discharged with a normal or close to normal serum creatinine. Their average length of hospital stay was 12.1 ± 4.8 days. Conclusions Acute kidney injury may occur shortly after intravenous infusion of andrographolide, with symptoms including flank pain, decreased urine output, and nausea or vomiting. The pathological change might be acute tubular necrosis. Renal replacement therapy may be needed in some patients and with a good recovery rate. The mechanisms of andrographolide induced AKI need to be further studied. Summary at a Glance This is the first description of acute renal failure after intravenous infusion of andrographolide, a component of the Chinese herb, Andrographis paniculata. Acute tubular necrosis is the renal lesion, and patients usually recover with supportive management.
机译:目的一些中草药因其肾脏毒性而闻名。穿心莲内酯是传统药材穿心莲的主要成分,在中国被广泛用于治疗上,下呼吸道感染和痢疾等。该研究的目的是鉴定和总结任何归因于肾脏损伤的病例在中国文学中的应用方法对1978年1月至2013年8月间穿心莲内酯诱发的急性肾损伤(AKI)的病例报道进行系统分析。结果我们确定了26例穿心莲内酯诱导的AKI患者(男22例,女4例),平均年龄31.3岁(范围:21个月至47岁)。每天一次静脉滴注100-750 mg(58%500 mg)穿心莲内酯于100-500 mL 5%葡萄糖溶液或生理盐水中。 1至6剂穿心莲内酯或1至6剂(19 [73.1%]患者仅得到1剂;累积剂量为690±670 mg)穿心莲内酯后出现不良事件,或在穿心莲内酯后0-96 h(中位数1 h)后出现不良事件。症状包括腰痛23例(88.5%),尿量减少5例(19.2%)和恶心或呕吐6例​​(23.1%)。实验室测试显示最大肌酐为352.8±184.1(158-889)μmol/ L,血尿素氮为12.1±7.6(4.0-40.6)mmol / L。尿液分析显示蛋白尿10例(38.5%),隐血8例(30.8%)。肾脏活检有两例,均显示出急性肾小管坏死。该不良事件的处理包括停药,保守治疗和肾脏替代治疗(6例,23.1%)。所有患者均康复并出院时血清肌酐正常或接近正常。他们的平均住院时间为12.1±4.8天。结论穿心莲内酯静脉输注后不久可能会发生急性肾损伤,其症状包括腹痛,尿量减少,恶心或呕吐。病理改变可能是急性肾小管坏死。在某些患者中可能需要进行肾脏替代治疗,并且具有良好的恢复率。穿心莲内酯诱导的AKI的机制有待进一步研究。概述这是静脉输注穿心莲内酯(中药穿心莲的一种成分)后发生的急性肾衰竭的首次描述。急性肾小管坏死是肾脏的病变,患者通常在支持治疗的情况下康复。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号